• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

风险与风险:老年人苯二氮䓬类药物减量的综述

Risk versus risk: a review of benzodiazepine reduction in older adults.

作者信息

Paquin Allison M, Zimmerman Kristin, Rudolph James L

机构信息

VA Boston Healthcare System (VABHS) , Boston, MA , USA +1 617 794 6401 ;

出版信息

Expert Opin Drug Saf. 2014 Jul;13(7):919-34. doi: 10.1517/14740338.2014.925444. Epub 2014 Jun 6.

DOI:10.1517/14740338.2014.925444
PMID:24905348
Abstract

INTRODUCTION

Benzodiazepines (BZD) are potentially inappropriate for older adults, yet their use persists. Patients and providers may hesitate to discontinue BZDs due to concerns for withdrawal or relapse. We reviewed the literature for BZD reduction protocols to examine common elements, safety and efficacy. A framework is proposed for clinicians to address BZD reduction challenges.

AREAS COVERED

Following a systematic literature review, this analysis included 28 studies of older out-patients tapering chronic BZDs. Populations included insomnia, depression and anxiety. Protocols included taper alone (32%), taper plus cognitive behavioral therapy (32%) and taper plus medication substitution (36%). Success rates were favorable for all modalities (mean 60%, median 67%, range 25 - 85%) and independent of dose or duration of use. Common schedules included a 25% dose reduction over 1 - 2 weeks until drug-free. Withdrawal symptoms included mainly mild psychological and somatic concerns. No serious safety events were reported.

EXPERT OPINION

BZD reduction protocols among older adults are feasible and successful. Given unique cognitive and functional abilities and comorbidities of older adults, a patient-centered approach to reduction is needed. Our framework guides clinicians in planning and persisting with BZD reduction, while our checklist addresses tailored tapers. Monitoring and support is emphasized, and taper modifications are proposed for struggling patients.

摘要

引言

苯二氮䓬类药物(BZD)对老年人可能存在潜在的不适用性,但其使用仍在持续。由于担心戒断反应或复发,患者和医疗服务提供者可能会犹豫是否停用BZD。我们查阅了有关BZD减量方案的文献,以研究其共同要素、安全性和有效性。本文为临床医生应对BZD减量挑战提出了一个框架。

涵盖领域

在进行系统的文献综述后,该分析纳入了28项关于老年门诊患者逐渐减少慢性BZD使用的研究。研究人群包括失眠、抑郁和焦虑患者。方案包括单纯减量(32%)、减量加认知行为疗法(32%)和减量加药物替代(36%)。所有方式的成功率都较好(平均60%,中位数67%,范围25%-85%),且与使用剂量或持续时间无关。常见的方案包括在1-2周内将剂量降低25%,直至停药。戒断症状主要包括轻度的心理和躯体问题。未报告严重的安全事件。

专家意见

老年人的BZD减量方案是可行且成功的。鉴于老年人独特的认知和功能能力以及合并症,需要采取以患者为中心的减量方法。我们的框架指导临床医生规划并坚持进行BZD减量,而我们的清单则涉及量身定制的减量方案。强调了监测和支持,并为减量困难的患者提出了调整方案。

相似文献

1
Risk versus risk: a review of benzodiazepine reduction in older adults.风险与风险:老年人苯二氮䓬类药物减量的综述
Expert Opin Drug Saf. 2014 Jul;13(7):919-34. doi: 10.1517/14740338.2014.925444. Epub 2014 Jun 6.
2
Psychosocial interventions for benzodiazepine harmful use, abuse or dependence.针对苯二氮䓬类药物有害使用、滥用或依赖的心理社会干预措施。
Cochrane Database Syst Rev. 2015;2015(5):CD009652. doi: 10.1002/14651858.CD009652.pub2.
3
A systematic review of phenibut withdrawal focusing on complications, therapeutic approaches, and single substance versus polysubstance withdrawal.苯环利定戒断的系统回顾:关注并发症、治疗方法以及单一物质与多种物质戒断。
Clin Toxicol (Phila). 2023 Nov;61(11):941-951. doi: 10.1080/15563650.2023.2285702. Epub 2023 Dec 19.
4
Treating Benzodiazepine Withdrawal in a Bridge Clinic.在过渡诊所治疗苯二氮䓬类药物戒断反应。
J Addict Med. 2024;18(6):649-656. doi: 10.1097/ADM.0000000000001334. Epub 2024 Jun 26.
5
Pharmacological interventions for benzodiazepine discontinuation in chronic benzodiazepine users.慢性苯二氮䓬类药物使用者停用苯二氮䓬类药物的药理学干预措施。
Cochrane Database Syst Rev. 2018 Mar 15;3(3):CD011481. doi: 10.1002/14651858.CD011481.pub2.
6
Withdrawal versus continuation of chronic antipsychotic drugs for behavioural and psychological symptoms in older people with dementia.痴呆症老年人行为和心理症状的慢性抗精神病药物撤药与继续用药对比
Cochrane Database Syst Rev. 2013 Mar 28(3):CD007726. doi: 10.1002/14651858.CD007726.pub2.
7
Safety of Phenobarbital Versus Benzodiazepines for Alcohol Withdrawal in Critically Ill Patients With Primary Neurologic Injuries.苯巴比妥与苯二氮䓬类药物用于原发性神经损伤重症患者酒精戒断的安全性比较
Ann Pharmacother. 2025 Mar;59(3):205-212. doi: 10.1177/10600280241271156. Epub 2024 Aug 20.
8
Falls prevention interventions for community-dwelling older adults: systematic review and meta-analysis of benefits, harms, and patient values and preferences.社区居住的老年人跌倒预防干预措施:系统评价和荟萃分析的益处、危害以及患者的价值观和偏好。
Syst Rev. 2024 Nov 26;13(1):289. doi: 10.1186/s13643-024-02681-3.
9
Olanzapine for the prevention and treatment of cancer-related nausea and vomiting in adults.奥氮平用于预防和治疗成人癌症相关性恶心和呕吐。
Cochrane Database Syst Rev. 2018 Sep 21;9(9):CD012555. doi: 10.1002/14651858.CD012555.pub2.
10
Phototherapy for atopic eczema.光疗治疗特应性皮炎。
Cochrane Database Syst Rev. 2021 Oct 28;10(10):CD013870. doi: 10.1002/14651858.CD013870.pub2.

引用本文的文献

1
Comparing Fourteen Behavioral Science Electronic Health Record Deprescribing Tools in Older Adults: NUDGE-EHR Adaptive Trial.比较针对老年人的十四种行为科学电子健康记录减药工具:NUDGE-EHR适应性试验
J Am Geriatr Soc. 2025 Jul 4. doi: 10.1111/jgs.19609.
2
Identification of Barriers and Needs in the Discontinuation of Benzodiazepine Receptor Agonists in Elderly Patients of a Rural Community-A Qualitative Study.农村社区老年患者停用苯二氮䓬受体激动剂的障碍与需求识别——一项定性研究
Geriatrics (Basel). 2025 Feb 1;10(1):18. doi: 10.3390/geriatrics10010018.
3
Pragmatic trial evaluating the impact of simulation training on high-risk prescribing to older adults by junior physicians.
评价模拟培训对低年资医生为老年患者开具高危药物处方的影响的实用临床试验。
J Am Geriatr Soc. 2024 May;72(5):1420-1430. doi: 10.1111/jgs.18862. Epub 2024 Mar 8.
4
Patient values and preferences regarding communicating risk versus benefit of benzodiazepine initiation: A cross-sectional survey study.患者关于苯二氮䓬类药物起始治疗风险与获益沟通的价值观和偏好:一项横断面调查研究。
Health Sci Rep. 2023 Dec 1;6(12):e1597. doi: 10.1002/hsr2.1597. eCollection 2023 Dec.
5
Alliance for Sleep Clinical Practice Guideline on Switching or Deprescribing Hypnotic Medications for Insomnia.睡眠联盟失眠症催眠药物换药或减药临床实践指南。
J Clin Med. 2023 Mar 25;12(7):2493. doi: 10.3390/jcm12072493.
6
CDC Clinical Practice Guideline for Prescribing Opioids for Pain - United States, 2022.美国疾病预防控制中心 2022 年《疼痛阿片类药物处方临床实践指南》。
MMWR Recomm Rep. 2022 Nov 4;71(3):1-95. doi: 10.15585/mmwr.rr7103a1.
7
Prescribing decision making by medical residents on night shifts: A qualitative study.夜间值班住院医师的处方决策:一项定性研究。
Med Educ. 2022 Oct;56(10):1032-1041. doi: 10.1111/medu.14845. Epub 2022 Jun 6.
8
Experiences with benzodiazepine use, tapering, and discontinuation: an Internet survey.苯二氮䓬类药物使用、逐渐减量及停药的经验:一项互联网调查。
Ther Adv Psychopharmacol. 2022 Apr 25;12:20451253221082386. doi: 10.1177/20451253221082386. eCollection 2022.
9
A deprescribing medication program to evaluate falls in older adults: methods for a randomized pragmatic clinical trial.一项用于评估老年人跌倒情况的减药计划:随机实用临床试验方法
Trials. 2022 Apr 4;23(1):256. doi: 10.1186/s13063-022-06164-5.
10
Current practice in benzodiazepine receptor agonists deprescribing on acute geriatric wards: a cohort study.苯二氮䓬类受体激动剂在急性老年病房逐渐减停的现行实践:一项队列研究。
BMC Geriatr. 2022 Feb 1;22(1):88. doi: 10.1186/s12877-022-02753-w.